Reinsurance
Reinsurers Maintain Upward Pricing Momentum—But Will It Last?
Positive pricing momentum—it's the favorite phrase of many reinsurers, who are hoping that the momentum they've seen in 2019 will continue during the coming January renewals and beyond. The ...
Chubb Chief Digital Officer Ringsted Sounds Off on Innovation, ITC and the Future
Sean Ringsted was one of the 7,000 or so people who attended the 2019 InsureTech Connect Conference, held Sept. 23 to 25 in Las Vegas. Ringsted is executive vice president, chief digital officer and ...
Carrier Technology Shopping Lists
If this were the Christmas holiday season for insurance carriers, machine learning, big data, analytics and security would be high on their shopping lists. Insurer IT spending is growing for 2020, ...
Brexit Business Opportunity: More Deals in Legacy General Insurance Policies
Britain's impending departure from the European Union is creating expansion opportunities for specialist general insurers who buy up and manage policies closed to new customers. Whether Britain ...
Could Your USB Cable Connect You to Hackers? — and More CM Risk Alerts
Some of the technology meant to help in your daily life may be hurting you as well. A modified USB cable could leave you connected to the bad guys. Your virtual assistant may be opening the backdoor ...
Reinsurers Look at Cyber’s Massive Growth Possibilities—With Caution
Reinsurers are aware they must constantly invent new solutions in order to stay relevant for their clients. Yet, they admit they are sometimes challenged to close the protection gap for new and ...
Executives On The Move at BHSI and Marsh & McLennan
Berkshire Hathaway Specialty Insurance hired veteran executives from RSA, Chubb and Allianz to fill three key leadership positions in Madrid. Marsh & McLennan made executive appointments in two ...
J&J Offers $4B to Settle Opioid Claims; Distributors Agree to Pay $18B
Johnson & Johnson has offered to pay $4 billion to settle all claims accusing the company of helping fuel the U.S. opioid epidemic, as part of a potentially larger deal involving drugmakers and ...